Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
04/2001
04/12/2001WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
04/12/2001WO2001025181A1 Carboxylic acid derivatives and drugs containing the same
04/12/2001WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
04/12/2001WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
04/12/2001WO2001024786A1 Preventive or therapeutic drugs for diabetes
04/12/2001WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
04/12/2001DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection
04/12/2001DE19948101A1 New substituted aryl- and heteroaryl-alkanes are serine protease and thrombin inhibitors, used for treatment of e.g. deep vein thrombosis or stroke
04/12/2001CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy
04/12/2001CA2386373A1 Method for improving the solubility of tricyclic amino alcohol derivatives
04/12/2001CA2385972A1 Novel diarylamide derivatives and use thereof as medicines
04/12/2001CA2372715A1 Preventive or therapeutic drugs for diabetes
04/11/2001EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds
04/11/2001EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase
04/11/2001EP1089966A1 Novel compounds useful in pain management
04/11/2001EP1089964A1 Hydrazine derivatives
04/11/2001EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
04/11/2001CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
04/11/2001CN1291100A Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents
04/11/2001CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives
04/11/2001CN1064349C Novel tricyclic amide, its preparing method and medicinal composition
04/10/2001US6215016 Hematopoietic agents; preventing cytopenia
04/10/2001US6215005 (2-(2-thienyl)ethylamino)(2-halophenyl)acetonitrile; reacting alkali metal cyanide, o-halobenzaldehyde and 2-(2-thienyl)-ethylamine; cyanation, reduction, alkylation, amination
04/10/2001US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease
04/10/2001US6214883 Benzamidoxime prodrugs as antipneumocystic agents
04/10/2001US6214877 Antidiabetic agents; modulator of glucose concentration
04/10/2001US6214859 Psychological disorders; alzheimer's disorders; parkinson'sdisorders
04/10/2001US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production
04/10/2001US6214481 Organic blue-emitting layer sandwiched between two electrodes
04/07/2001CA2285578A1 Rhodium-catalyzed addition of alkenyl- and aryltrifluoroborates to aldehydes and enones
04/05/2001WO2001023496A1 Organic electroluminescent element
04/05/2001WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives
04/05/2001WO2001023378A1 Pharmaceutically active sulfonamide derivatives
04/05/2001WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
04/05/2001WO2001023369A2 Process for preparing benzoic acids
04/05/2001WO2001023352A2 Preparation of sulfonyl imine compounds
04/05/2001WO2001023350A1 Thioalkylamine derivatives and process for the preparation thereof
04/05/2001WO2001023347A1 Novel aromatic compounds
04/05/2001WO2000059897A3 Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds
04/05/2001DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter
04/05/2001CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives
04/05/2001CA2378028A1 Preparation of sulfonyl imine compounds
04/04/2001EP1088842A1 Optically active polythiophene
04/04/2001EP1088821A1 Pharmaceutically active sulfonamide derivatives
04/04/2001EP1088815A1 Pharmaceutically active sulfonyl amino acid derivatives
04/04/2001EP1087941A2 Thiolesters and uses thereof
04/04/2001EP1087939A1 Process for preparation of pyrimidinone derivatives
04/04/2001EP1087934A1 Aminocyclohexyl ether compounds and uses thereof
04/04/2001EP0748803B1 Process for producing carboxylic acid derivative
04/04/2001CN1290247A Process and intermediates useful to make antifolates
04/04/2001CN1290164A Inhibition of RAF kinase using substituted heterocyclic ureas
04/04/2001CN1064041C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them
04/03/2001US6211364 Process for preparing indane-like compounds
04/03/2001US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
04/03/2001US6211240 O-benzyl oxime ether derivatives and their use as pesticides
04/03/2001US6211234 Substituted phenyl compounds
04/03/2001US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction
04/03/2001US6211178 Antiprotozoa agents for coccidioides; cyclization
03/2001
03/29/2001WO2001021606A1 Liquid crystal compounds
03/29/2001WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp)
03/29/2001WO2001021584A1 Tyrosine derivatives
03/29/2001WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
03/29/2001WO2001021577A2 Melanin concentrating hormone antagonist
03/29/2001WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens
03/29/2001WO2001002350A3 Novel amino sulfonamides and amido sulfonamides as antiviral agents
03/29/2001WO2000061232A3 Methods and compositions for the treatment and prevention of lung disease involving a specific rar-beta antagonist
03/29/2001WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's)
03/29/2001DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments
03/29/2001CA2386474A1 Melanin concentrating hormone antagonist
03/28/2001EP1086098A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
03/28/2001EP1086091A1 Hiv integrase inhibitors
03/28/2001EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof
03/28/2001CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
03/28/2001CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/27/2001US6208719 Method and apparatus for telecommunications having automatic network adaptations and silent mode operations
03/27/2001US6207701 Urokinase inhibitors
03/27/2001US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection
03/27/2001US6207685 Inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals by administering 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in pure racemic, diastereoisomeric or enantiomeric form
03/22/2001WO2001019821A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists
03/22/2001WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
03/22/2001WO2001019811A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
03/22/2001WO2001019809A1 Tryptase inhibitors
03/22/2001WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors
03/22/2001WO2001019798A2 INHIBITORS OF FACTOR Xa
03/22/2001WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
03/22/2001WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
03/22/2001WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/22/2001WO2001019770A2 Rxr modulators with improved pharmacologic profile
03/22/2001WO2000040576A3 Thiopyran compounds as inhibitors of mmp
03/22/2001WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection
03/22/2001DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride
03/22/2001CA2385589A1 Inhibitors of factor xa
03/22/2001CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
03/22/2001CA2384763A1 Tryptase inhibitors
03/22/2001CA2383565A1 Rxr modulators with improved pharmacologic profile
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001EP1085009A1 Indan derivatives
03/21/2001EP1084711A1 Remedies for itching containing pgd 2? antagonists